Update shared on17 Jul 2025
Fair value Decreased 5.41%Despite an improved revenue growth outlook for Kanadevia, a higher discount rate has outweighed these gains, resulting in a lowered consensus analyst price target from ¥1110 to ¥1050.
What's in the News
- Board approved proposal to amend Articles of Incorporation, specifically abolishing the position of Counselors to enhance governance and transparency.
- Proposal to amend Articles of Incorporation will be submitted to the 128th Ordinary General Meeting of Shareholders.
- Announced increased annual dividend to JPY 25.00 per share from JPY 23.00, pending shareholder approval.
- Issued FY2026 consolidated guidance: net sales ¥620,000 million, operating income ¥27,000 million, net profit ¥16,000 million, net income per share ¥95.13.
Valuation Changes
Summary of Valuation Changes for Kanadevia
- The Consensus Analyst Price Target has fallen from ¥1110 to ¥1050.
- The Consensus Revenue Growth forecasts for Kanadevia has significantly risen from 2.1% per annum to 2.4% per annum.
- The Discount Rate for Kanadevia has risen from 7.36% to 8.07%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.